Selective unresponsiveness to conformational B cell epitopes of the myelin oligodendrocyte glycoprotein in H-2b mice

被引:31
作者
Bourquin, C
Schubart, A
Tobollik, S
Mather, I
Ogg, S
Liblau, R
Linington, C
机构
[1] Max Planck Inst Neurobiol, Dept Neuroimmunol, D-82152 Martinsried, Germany
[2] Univ Maryland, Dept Anim & Avian Sci, College Pk, MD 20742 USA
[3] Hop La Pitie Salpetriere, Inst Natl Sante & Rech Med, Unite 546, Paris, France
[4] Univ Aberdeen, Dept Med & Therapeut, Aberdeen, Scotland
关键词
D O I
10.4049/jimmunol.171.1.455
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Autoantibodies directed against conformation-dependent epitopes of the extracellular domain of the myelin oligodendrocyte glycoprotein (MOG(Igd)) play a major role in the immunopathogenesis of demyelination in experimental autoimmune encephalomyelitis. We now demonstrate that one or more genes encoded within the MHC selectively censor the ability of H-2(b) mice to mount this conformation-dependent autoantibody response, while leaving T and B cell responses to linear MOG(Igd) epitopes intact. This novel form of selective B cell unresponsiveness discriminates between pathogenic and nonpathogenic Ab responses to MOG and determines whether or not Ab-dependent effector mechanisms play an important role in the pathogenesis of MOG-induced experimental autoimmune encephalomyelitis in the mouse.
引用
收藏
页码:455 / 461
页数:7
相关论文
共 30 条
[1]  
Attanasio R, 1997, FEMS IMMUNOL MED MIC, V17, P207, DOI 10.1111/j.1574-695X.1997.tb01014.x
[2]  
Bourquin C, 2000, EUR J IMMUNOL, V30, P3663
[3]   Epitope specificity of demyelinating monoclonal autoantibodies directed against the human myelin oligodendrocyte glycoprotein (MOG) [J].
Brehm, U ;
Piddlesden, SJ ;
Gardinier, MV ;
Linington, C .
JOURNAL OF NEUROIMMUNOLOGY, 1999, 97 (1-2) :9-15
[4]   DIFFERENTIAL ULTRASTRUCTURAL-LOCALIZATION OF MYELIN BASIC-PROTEIN, MYELIN OLIGODENDROGLIAL GLYCOPROTEIN, AND 2',3'-CYCLIC NUCLEOTIDE 3'-PHOSPHODIESTERASE IN THE CNS OF ADULT-RATS [J].
BRUNNER, C ;
LASSMANN, H ;
WAEHNELDT, TV ;
MATTHIEU, JM ;
LININGTON, C .
JOURNAL OF NEUROCHEMISTRY, 1989, 52 (01) :296-304
[5]  
Derbinski J, 2001, NAT IMMUNOL, V2, P1032, DOI 10.1038/ni723
[6]  
Gautam AM, 1998, J IMMUNOL, V161, P60
[7]   Identification of autoantibodies associated with myelin damage in multiple sclerosis [J].
Genain, CP ;
Cannella, B ;
Hauser, SL ;
Raine, CS .
NATURE MEDICINE, 1999, 5 (02) :170-175
[8]   The fine specificity of the myelin oligodendrocyte glycoprotein autoantibody response in patients with multiple sclerosis and normal healthy controls [J].
Haase, CG ;
Guggenmos, J ;
Brehm, U ;
Andersson, M ;
Olsson, T ;
Reindl, M ;
Schneidewind, JM ;
Zettl, UK ;
Heidenreich, F ;
Berger, T ;
Wekerle, H ;
Hohlfeld, R ;
Linington, C .
JOURNAL OF NEUROIMMUNOLOGY, 2001, 114 (1-2) :220-225
[9]   B cell development pathways [J].
Hardy, RR ;
Hayakawa, K .
ANNUAL REVIEW OF IMMUNOLOGY, 2001, 19 :595-621
[10]  
LEBAR R, 1986, CLIN EXP IMMUNOL, V66, P423